No CrossRef data available.
Drugs for AIDS/HIV: Assessing the Evidence
Published online by Cambridge University Press: 10 March 2009
Abstract
This article highlights factors that may cause bias in individual controlled trials or meta-analysis of zidovudine (AZT) in HIV disease. The overall benefit of AZT and antiretroviral drug combinations in the progression of HIV disease is probably greater than has been or can ever be shown in an ethical controlled trial.
- Type
- Research Notes
- Information
- International Journal of Technology Assessment in Health Care , Volume 14 , Issue 3 , Summer 1998 , pp. 567 - 572
- Copyright
- Copyright © Cambridge University Press 1998